The Shareholders Foundation, Inc. announces that a lawsuit is pending on behalf of certain purchasers of NASDAQ: KERX shares against Keryx Biopharmaceuticals over alleged Violations of Securities Laws. Investors who purchased shares of Keryx Biopharmaceuticals (KERX) prior to February 25, 2016 and continue to hold any NASDAQ: KERX shares have …
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, announces that Keryx Biopharmaceuticals Inc. …
Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) (http://www.rgrdlaw.com/cases/keryx/) today announced that a class action has been commenced on behalf of purchasers of Keryx Biopharmaceuticals, Inc. (“Keryx” or the “Company”) (KERX) common stock during the period between March 2, 2016 and July 29, 2016, inclusive (the “Class Period”). This action was …
Lundin Law PC (the “Firm”) announces that a class action lawsuit has been filed against Keryx Biopharmaceuticals Inc. (“Keryx” or the “Company”) (Nasdaq: KERX) concerning possible violations of federal securities laws between February 25, 2016 and August 1, 2016 (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period …